IPP Bureau
Ocugen submits IND application with U.S. FDA for Covaxin phase 3 trial
By IPP Bureau - October 28, 2021
The Phase 3 study is designed to bridge data collected from the vaccine efficacy trial conducted in India to the U.S. population
Novartis receives priority review by U.S. FDA and filing acceptance by EMA for Kymriah
By IPP Bureau - October 28, 2021
Kymriah, the first-ever FDA-approved CAR-T cell therapy, is currently available in 30 countries in one or more indications
Rainbow hospital gives new lease of life to infant on ECMO support
By IPP Bureau - October 28, 2021
The youngest child in India to survive ECMO after undergoing bone marrow transplant for a rare disease
AstraZeneca partners with India-Sweden Healthcare Innovation Centre and AIIMS to upskill nurses
By IPP Bureau - October 28, 2021
This capability programme aims to upskill 5000 nurses across the country in the next year by converting the current modules into an e-learning one
Oasis Fertility forays into Karnataka plans 10 more centres
By IPP Bureau - October 28, 2021
It plans to double its network to 50 centres across India in the next three years
Thermo Fisher Scientific unveils Q Digital PCR system
By IPP Bureau - October 28, 2021
It is the first integrated digital PCR solution ideal for oncology, cell and gene therapy development
_1.png "Honeywell launches real-time health monitoring system")
Honeywell launches real-time health monitoring system
By IPP Bureau - October 28, 2021
Combination of hardware and data analytics software improves real-time and remote patient monitoring; digitizes and automates time-consuming and critical tasks for medical personnel, reducing administrative tasks by 35 per cent
D2C pet care brand Wiggles.in raises US $ 5.5 million in its Pre-Series A round
By IPP Bureau - October 28, 2021
This funding will help the start-up consolidate its position as a one-stop destination for pet parents as they holistically reimagine the entire pet care ecosystem
Sun Pharma introduces treatment for plaque psoriasis in Canada
By IPP Bureau - October 28, 2021
Moderate-to-severe plaque psoriasis affects about 35 per cent of patients. A key challenge is that many treatments stop working overtime and symptoms return
Cipla consolidated net profit at Rs 711.36 cr. in Q2FY22
By IPP Bureau - October 27, 2021
Cipla has reported consolidated financial results for the period ended September 30, 2021
Torrent Pharma consolidated PAT at Rs 316 cr. in Q2FY22
By IPP Bureau - October 27, 2021
Torrent Pharmaceuticals Limited has reported consolidated financial results for the period ended September 30, 2021
Sanofi India PAT at Rs. 529.8 cr in Q3CY21
By IPP Bureau - October 27, 2021
The Board of Directors of Sanofi India Limited, at its meeting held on October 26th 2021 have approved the unaudited Standalone financial results of the company for the period ended September 30, 2021
WHO selects Medigen’s Covid-19 vaccine for solidarity trial
By IPP Bureau - October 27, 2021
Following the review of around 20 candidate vaccines by the external advisory group, MVC's vaccine was selected as one of two to be included in the global trial
Dr Lal PathLabs to acquire Suburban Diagnostics for Rs 925 crore
By IPP Bureau - October 27, 2021
Dr Lal PathLabs revenue contribution from west India to go up from 10% to 24% post-acquisition basis FY21
4baseCare partners with U.S. based Cellworks for personalised cancer care
By IPP Bureau - October 27, 2021
The collaboration aims to deliver greater insights to the oncology fraternity, predict patient therapy responses and enable therapy selection resulting in optimal treatment outcomes.
